Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term ticagrelor study for elective PCI in stable coronary heart disease
ChiCTR-TRC-14004377Phase 4Completed
- Sponsor
- Xinhua Hospital
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ticagrelor and clopidogrel in coronary arteriosclerosis (3 arms), sponsored by Xinhua Hospital. Primary endpoints: High-sensitivity troponin T, Troponin T and 2 more. Started Jan 2014; status: completed.
02
Drugs
ticagrelorclopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-14004377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004377.